Invest now
Unjha Formulations share price
Extreme risk
You have to be logged in to add this to Watchlist.- ₹31.50(1.61%)October 16, 2026 15:27:03 PM IST
- NSE
- BSE
- Vol : 0.74 K (NSE + BSE)Last 20 day avg : 2.46 K
Unjha Formulations is trading 1.61% upper at Rs 31.50 as compared to its last closing price. Unjha Formulations has been trading in the price range of 31.95 & 29.55. Unjha Formulations has given 24.00% in this year & -4.91% in the last 5 days. Unjha Formulations has TTM P/E ratio 18.67 as compared to the sector P/E of 32.33.The company posted a net profit of 0.16 Crores in its last quarter.Listed peers of Unjha Formulations include Sun Pharmaceutical Industries (-0.03%), Divi's Laboratories (1.27%), Torrent Pharmaceuticals (-1.00%).The Mutual Fund holding in Unjha Formulations was at -% in . The MF holding has - from the last quarter. The FII holding in Unjha Formulations was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 17 Oct 2026, 04:58 AM IST
- BetaLow volatility-0.30Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.00The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation0.82The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Unjha Formulations Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,760.00 | -0.03 | 4,22,273.00 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 9,144.50 | 1.27 | 2,42,757.74 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,560.00 | -1.00 | 1,73,441.54 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,325.00 | -0.65 | 1,07,041.24 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,124.30 | -1.44 | 1,12,149.36 | 21.19 | 4.24 | 0.09 | 14.22 |
Unjha Formulations Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-08-03 | Quarterly Results |
| 2026-05-18 | Audited Results |
| 2026-02-04 | Quarterly Results |
| 2025-11-10 | Quarterly Results |
| 2025-08-06 | Quarterly Results |
About the company Unjha Formulations
- IndustryBiotechnology & Drugs
- ISININE576D01015
- BSE Code531762
- NSE Code
Unjha Formulations Limited is an India-based company, which is engaged in manufacturing and exporting of isabgol (psyllium) ayurvedic products. The Company is engaged in service to the isabgol (psyllium) ayurvedic formulation profession. It also manufactures all kinds of small volume ayurvedic isabgol (psyllium) powder and is tested at its plant with a modern and well equipped physico chemical and micro biological quality control laboratory. The Company’s Anchor Sat-Isabgol is available in 50 grams (gms), 100 gm, 200 gm, and 400 gm. Its isabgo husk formulation is available in the elaichi flavor. The Company’s Fibron is available in 100 gms and 300 gms. Its Isabgol Poder is available in the orange flavor. Its Fibron SF (sugar-free) is available in 100 gm and 300 gm.
Unjha Formulations Share Price FAQs
Unjha Formulations is trading at 31.50 as on Fri Oct 16 2026 09:57:03. This is 1.61% upper as compared to its previous closing price of 31.00.
The market capitalization of Unjha Formulations is 14.11 Cr as on Fri Oct 16 2026 09:57:03.
The 52 wk high for Unjha Formulations is 36.38 whereas the 52 wk low is 17.52
Unjha Formulations can be analyzed on the following key metrics -
- TTM P/E: 18.67
- Sector P/E: 32.33
- Dividend Yield: 0.00%
- D/E ratio: -
Unjha Formulations reported a net profit of 0.70 Cr in 2026.
Quick Links
EQUITY QUICK LINKS
Unjha Formulations QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.